Press release
T Lymphocyte Activation Antigen CD80 Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027
The global T lymphocyte activation antigen CD80 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). CD80 is a costimulatory molecule that is known for its role in T-cell activation. It also regulates the activity of normal and malignant B cells. The major factor driving the demand for T lymphocyte activation antigen CD80 is the increasing prevalence of acute myelocytic leukemia (AML) across the globe.According to the American Society of Clinical Oncology (ASCO), AML is uncommon and makes up about 1% of cancers. Additionally, in 2021, an estimated 20,240 people of all ages which include 11,230 men and boys and 9,010 women and girls was diagnosed with AML in the US. Furthermore, AML is the second most common type of leukemia diagnosed in adults and children, however, most cases occur in adults and makes up 31% of all adult leukemia cases. Moreover, the average age of diagnosis is 68 years, however, it can be diagnosed at any age. Hence, the increasing prevalence of AML is driving the demand for T lymphocyte activation antigen CD80 as it is used as immunotherapy by identifying neoplastic cells and sparing healthy tissue which in turn is driving the growth of the market.
To Request a Sample of our Report on T Lymphocyte Activation Antigen CD80 Market: https://www.omrglobal.com/request-sample/t-lymphocyte-activation-antigen-cd80-market
Some major players in the market include Bristol-Myers Squibb Co, and KAHR Medical Ltd, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2021, AstraZeneca announced positive high-level results from the Phase III Himalaya clinical trial of Imfinzi (durvalumab) plus tremelimumab as first-line therapy for unresectable hepatocellular carcinoma (HCC) patients. Tremelimumab is an anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) antibody.
Market Coverage
· The market number available for - 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Type
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- Bristol-Myers Squibb Co, and KAHR Medical Ltd, among others.
(Get 15% Discount on Buying this Report)
A full Report of T Lymphocyte Activation Antigen CD80 Market is Available @ https://www.omrglobal.com/industry-reports/t-lymphocyte-activation-antigen-cd80-market
Global T Lymphocyte Activation Antigen CD80 Market Report by Segment
By Type
• Abatacept
• Abatacept Biosimilar
• CUE-201
• KAHR-102
• Others
By Application
• Metabolic Disorders
• Autoimmune Disorders
• Acute Myelocytic Leukemia
• Others
Global T Lymphocyte Activation Antigen CD80 Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release T Lymphocyte Activation Antigen CD80 Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027 here
News-ID: 2577684 • Views: …
More Releases from Orion Market Research

Content Analytics, Discovery and Cognitive Software Market Competitive Dynamics: …
Content Analytics, Discovery, and Cognitive Software Market: In 2023, the market was valued at USD 4.5 billion and is anticipated to reach USD 22.8 billion by 2033, growing at a CAGR of 17.8% from 2024 to 2033.
The market growth is attributed to the adoption of artificial intelligence (AI) and machine learning (ML) technologies in various industries including administration, healthcare, pharmaceuticals, retail, and others to optimize current organizational data extraction and…

Shaojiu Market Size, Share, Trends, Growth, Analysis and Forecasts 2033
The global specialty spirits market, which includes shaojiu, was valued at USD 32.6 billion in 2024 and is projected to reach USD 47.8 billion by 2033, exhibiting a CAGR of 4.15% during 2025-2033.
Shaojiu, also known as baijiu, is a traditional Chinese distilled spirit made primarily from grains such as sorghum, rice, wheat, barley, or millet. It is characterized by its high alcohol content and diverse flavor profiles, which vary based…

Intelligent Document Processing Market Competitive Dynamics: ABBYY, UiPath, IBM, …
Intelligent Document Prcessing Market: The market size was valued at USD 1.1 billion in 2023 and is expected to grow to USD 5.2 billion by 2033, indicating a CAGR of 17.1% during the forecast period.
The market growth is attributed to the rising influence of artificial intelligence (AI) and machine learning (ML) technologies in document processing across industries. The adoption is stimulated by technological advancements in document processing, as companies have…

Silicon Anode Lithium-Ion Battery Market Competitive Dynamics: Panasonic, LG Che …
Silicon Anode Lithium-Ion Battery Market: In 2023, the market was valued at approximately USD 1.2 billion and is projected to reach USD 10.4 billion by 2033, reflecting a CAGR of 24.1% from 2024 to 2033.
The growing demand for safe energy solutions has driven the growth of the global silicon anode lithium-ion battery market. Silicon anode batteries, which provide high-energy and safe battery solutions are growing in popularity due to the…
More Releases for CD80
T Lymphocyte Activation Antigen CD80 Market Pegged for Robust Expansion by 2027 …
This T Lymphocyte Activation Antigen CD80 market report provides in-depth market information to help firms make better business decisions and advance growth plans based on market predictions and trends. The research focuses on a group examination of data from primary and secondary sources. This T Lymphocyte Activation Antigen CD80 market report looks at new developments, trends, and perspectives, as well as forecasts the market's current state and future prospects from…
SDN and NFV Technology in Telecom Network Transformation Market will Record Rapi …
This SDN and NFV Technology in Telecom Network Transformation market report's major objective is to evaluate, outline, and predict the various kinds, applications, makers, and regions. The research goes into great detail on the key variables driving growth in the economy (drivers, limitations, possibilities, and industry-specific constraints). The goal of the research is to conduct a critical evaluation of the micro markets in terms of their individual market size, opportunities,…
T Lymphocyte Activation Antigen CD80 Market 2019-2025 by Type, Application and G …
UpMarketResearch offers a latest published report on “Global T Lymphocyte Activation Antigen CD80 Market Industry Analysis and Forecast 2019-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 111 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. The report contains basic, secondary and advanced information pertaining to the T Lymphocyte…
Immuno-Oncology Drugs Market Overview Till 2025 | Industry Insights, Trends, Ana …
According to World Health Organization (WHO), cancer is one of the major non-communicable diseases and the second-leading cause of death worldwide. According to International Agency for Research on Cancer (IARC) in 2012, there were around 14.1 million new cases, 8.8 million deaths, and 32.6 million people living with cancer worldwide. Immuno-oncology therapy is effective for treatment of cancers such as melanoma, bladder cancer, head and neck cancer, leukemia, lung, multiple…
In Depth Research on
“Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight:
* Nomenclature & Classification of CD Antigens
* Mechanism of CD Antigen Cancer Therapeutics
* Cancer CD Antigen Therapy Market Overview
* Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase
* Cancer CD Antigen Inhibitors Clinical Pipeline: 207 Drugs
* Marketed Cancer CD Antigen Inhibitors: 27 Drugs
* Majority of Cancer CD Antigen Inhibitors in Preclinical Phase: 70 Drugs
* Cancer CD Antigens…
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter …
The functionality of the T Lymphocyte Activation Antigen CD80 as a coreceptor activity and virus receptor activity helps in its growth and development. To analyze the related therapeutic development and assessment, Market Research Hub (MRH) has recently added a researched study titled as “T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H1 2017” to its vast report repository.
Request Free…